[1] SUNG H,FERLAY J,SIEGEL R,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
[2] DAVEY MG,DAVIES M,LOWERY AJ,et al.The role of microRNA as clinical biomarkers for breast cancer surgery and treatment [J].Int J Mol Sci,2021,22(15):8290.
[3] DAVEY MG,LOWERY AJ,MILLERN N,et al.MicroRNA expression profiles and breast cancer chemotherapy [J].Int J Mol Sci,2021,22(19):10812.
[4] GUPTA R,PONANGI R,INDRESH KG.Role of glycosylation in breast cancer progression and metastasis:implications for miRNA,EMT and multidrug resistance [J].Glycobiology,2023,33(7):545-555.
[5] WU J,ZHOU Z.MicroRNA-432 acts as a prognostic biomarker and an inhibitor of cell proliferation,migration,and invasion in breast cancer [J].Clin Breast Cancer,2021,21(4):e462-e470.
[6] RAMANTO KN,WIDIANTO KJ,WIBOWO SSH,et al.The regulation of microRNA in each of cancer stage from two different ethnicities as potential biomarker for breast cancer [J].Comput Biol Chem,2021,93:107497.
[7] SEDDIK MI,OSAMA O,JABIR MA,et al.Diagnostic values of microRNA 27a in breast cancer patients[J].Egypt J Immunol,2021,28(3):127-137.
[8] LOGINOV VI,BURDENNYY AM,FILIPPOVA EA,et al.Aberrant methylation of 21 microRNA genes in breast cancer:Sets of genes associated with progression and a system of markers for predicting metastasis[J].Bull Exp Biol Med,2021,172(1):67-71.
[9] OASKES SA.Endoplasmic reticulum stress signaling in cancer cells[J].Am J Pathol,2020,190(5):934-946.
[10] XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J (Engl),2022,135(5):584-590.
[11] BARZAMAN K,MORADI-KALBOLANDI S,HOSSEIN
ZADEH A,et al.Breast cancer immunotherapy:Current and novel approaches[J].Int Immunopharmacol,2021,98:p.107886.
[12] RAKHA EA,PAREJA FG.New advances in molecular breast cancer pathology[J].Semin Cancer Biol,2021,72:p.102-113.
[13] ZHOU S,QIAN K,YU S,et al.MiR-4429 alleviates malignant behaviors of lung adenocarcioma through Wnt/β-Catenin pathway[J].Cancer Biother Radiopharm,2021,9:2.
[14] WANG J,ZHANG L,WANG C,et al.LINC00313/miR-4429 axis provides novel biomarkers for the diagnosis and prognosis of non-small cell lung cancer [J].Acta Biochim Pol,2022,69(2):343-348.
[15] ZHU YM,CHEN P,SHI L,et al.MiR-4429 suppresses the malignant development of ovarian cancer by targeting YOD1[J].Eur Rev Med Pharmacol Sci,2020,24(17):8722-8730.
[16] SISINNI L,PIETRADESA M,LEPORE S,et al.Endoplasmic reticulum stress and unfolded protein response in breast cancer:The balance between apoptosis and autophagy and its role in drug resistance[J].Int J Mol Sci,2019,20(4):857.
[17] MARCINIAK SJ,CHAMBERS JE,RON D.Pharmacological targeting of endoplasmic reticulum stress in disease[J].Nat Rev Drug Discov,2022,21(2):115-140.
[18] BOUDREAU MW,DURAKI D,WANG L,et al.A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice[J].Sci Transl Med,2021,13(603):eabf1383.
[19] LIU X,SURYAVATHI V,SHOURYA K,et al.Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress[J].Nature Cancer,2022,3(7):866-848.
[20] COBLEIGH MA,LAYNG KV,MAUER E.Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers[J].Breast Cancer Res Treat,2023,12:28.
[21] XU Liben,WU Chaoyang,WANG Yuandong.The role of PI3K/Akt signal pathway in the development and progression of tumor [J].Modern Oncology,2021,29(01):177-180.
[22] PEREIRA B,CHIN SF,RUEDA OM,et al.The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes[J].Nat Commun,2016,7:11479.
[23] LAGER TW,CONNER C,KEARING CR,et al.Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling[J].Oncogene,2021,40(23):4050-4059.